These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22806342)

  • 1. Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes.
    Hou FQ; Zeng Z; Wang GQ
    Cell Biochem Biophys; 2012 Nov; 64(2):77-83. PubMed ID: 22806342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury.
    Pang L; Yang W; Hou F
    Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):48-56. PubMed ID: 28927656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.
    Robles-Diaz M; Lucena MI; Kaplowitz N; Stephens C; Medina-Cáliz I; González-Jimenez A; Ulzurrun E; Gonzalez AF; Fernandez MC; Romero-Gómez M; Jimenez-Perez M; Bruguera M; Prieto M; Bessone F; Hernandez N; Arrese M; Andrade RJ; ; ;
    Gastroenterology; 2014 Jul; 147(1):109-118.e5. PubMed ID: 24704526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry.
    Andrade RJ; Lucena MI; Kaplowitz N; García-Muņoz B; Borraz Y; Pachkoria K; García-Cortés M; Fernández MC; Pelaez G; Rodrigo L; Durán JA; Costa J; Planas R; Barriocanal A; Guarner C; Romero-Gomez M; Muņoz-Yagüe T; Salmerón J; Hidalgo R
    Hepatology; 2006 Dec; 44(6):1581-8. PubMed ID: 17133470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Features of Drug-induced Liver Injury According to Etiology.
    Lee BM; Lee WC; Jang JY; Ahn P; Kim JN; Jeong SW; Park EJ; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS
    J Korean Med Sci; 2015 Dec; 30(12):1815-20. PubMed ID: 26713057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent liver biochemistry abnormalities are more common in older patients and those with cholestatic drug induced liver injury.
    Fontana RJ; Hayashi PH; Barnhart H; Kleiner DE; Reddy KR; Chalasani N; Lee WM; Stolz A; Phillips T; Serrano J; Watkins PB;
    Am J Gastroenterol; 2015 Oct; 110(10):1450-9. PubMed ID: 26346867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced liver injury: A 2-year retrospective study of 1169 hospitalized patients in a single medical center.
    Woo HJ; Kim HY; Choi ES; Cho YH; Kim Y; Lee JH; Jang E
    Phytomedicine; 2015 Dec; 22(13):1201-5. PubMed ID: 26598920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug- and herb-induced liver injury: a case series from a single center.
    Dağ MS; Aydınlı M; Oztürk ZA; Türkbeyler IH; Koruk I; Savaş MC; Koruk M; Kadayıfçı A
    Turk J Gastroenterol; 2014 Feb; 25(1):41-5. PubMed ID: 24918129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics of drug-induced liver injury in 31 pediatric cases].
    Wang SZ; Gao S; Liu YM; Huang YL; Chen YS; Wang XX; Lin W; Huang CY; Liao HY
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):193-5. PubMed ID: 22475138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid and ursodesoxycholic Acid combination therapy in severe drug-induced liver injury.
    Wree A; Dechêne A; Herzer K; Hilgard P; Syn WK; Gerken G; Canbay A
    Digestion; 2011; 84(1):54-9. PubMed ID: 21304237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-induced liver injury: a cohort study on patients referred to the Danish transplant center over a five year period.
    Baekdal M; Ytting H; Skalshøi Kjær M
    Scand J Gastroenterol; 2017 Apr; 52(4):450-454. PubMed ID: 27973926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver enzyme abnormalities during concurrent use of herbal and conventional medicines in Korea: a retrospective study.
    Kim NH; Jung HY; Cho SY; Park SU; Park JM; Ko CN
    Phytomedicine; 2011 Nov; 18(14):1208-13. PubMed ID: 21802919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The characteristics and clinical outcome of drug-induced liver injury: a single-center experience.
    Idilman R; Bektas M; Cinar K; Toruner M; Cerit ET; Doganay B; Erden E; Bozkaya H; Bahar K; Karayalcin S; Soykan I; Palabiyikoglu M; Cetinkaya H; Yurdaydin C; Dokmeci A; Ozden A
    J Clin Gastroenterol; 2010 Jul; 44(6):e128-32. PubMed ID: 20551776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics of Patients with Drug-induced Liver Injury.
    Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
    Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry.
    Stephens C; Robles-Diaz M; Medina-Caliz I; Garcia-Cortes M; Ortega-Alonso A; Sanabria-Cabrera J; Gonzalez-Jimenez A; Alvarez-Alvarez I; Slim M; Jimenez-Perez M; Gonzalez-Grande R; Fernández MC; Casado M; Soriano G; Román E; Hallal H; Romero-Gomez M; Castiella A; Conde I; Prieto M; Moreno-Planas JM; Giraldez A; Moreno-Sanfiel JM; Kaplowitz N; Lucena MI; Andrade RJ;
    J Hepatol; 2021 Jul; 75(1):86-97. PubMed ID: 33539847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and prognostic markers in severe drug-induced liver disease.
    Björnsson E; Olsson R
    Hepatology; 2005 Aug; 42(2):481-9. PubMed ID: 16025496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of drug-induced liver injury from tumor necrosis factor antagonists.
    Björnsson ES; Gunnarsson BI; Gröndal G; Jonasson JG; Einarsdottir R; Ludviksson BR; Gudbjörnsson B; Olafsson S
    Clin Gastroenterol Hepatol; 2015 Mar; 13(3):602-8. PubMed ID: 25131534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
    Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.